Continuous Infusion of Recombinant Factor VIIa (NovoSeven®) in the Treatment of a Patient with Type III von Willebrand’s Disease and Alloantibodies against von Willebrand Factor
- 1 January 2000
- journal article
- letter
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 83 (04) , 633-634
- https://doi.org/10.1055/s-0037-1613878
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Platelet activity of high‐dose factor VIIa is independent of tissue factorBritish Journal of Haematology, 1997
- Precipitating antibodies in von Willebrand's diseaseNature, 1976